| NCT Number | NCT07009340 |
| Lead Sponsor | Renibus Therapeutics, Inc. |
| Conditions | Post-discharge Outcomes |
| Enrollment | 200 participants |
| Start Date | 2023-11-18 |
| Primary Completion | 2025-06-30 (estimated) |
| Study Completion | 2025-06-30 (estimated) |
| Updated on ClinicalTrials.gov | 2025-06-13 |